Education
About Us
Working with TipRanks
Follow Us
Nectar Lifesciences Ltd. (IN:NECLIFE)
:NECLIFE
Total Valuation
Nectar Lifesciences Ltd. has a market cap or net worth of ₹4.04B. The enterprise value is ₹4.02B.
Market Cap₹4.04B
Enterprise Value₹4.02B
Share Statistics
Nectar Lifesciences Ltd. has 224,260,970 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding224,260,970
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Nectar Lifesciences Ltd.’s return on equity (ROE) is <0.01 and return on invested capital (ROIC) is 6.21%.
Return on Equity (ROE)<0.01
Return on Assets (ROA)<0.01
Return on Invested Capital (ROIC)6.21%
Return on Capital Employed (ROCE)0.32
Revenue Per Employee9.99M
Profits Per Employee29.63K
Employee Count1,686
Asset Turnover0.77
Inventory Turnover1.55
Valuation Ratios
The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.
PE Ratio30.0
PS Ratio0.00
PB Ratio0.37
Price to Fair Value0.73
Price to FCF0.00
Price to Operating Cash Flow0.00
PEG Ratio0.41
Income Statement
In the last 12 months, Nectar Lifesciences Ltd. had revenue of 16.84B and earned 49.95M in profits. Earnings per share was 0.22.
Revenue16.84B
Gross Profit4.82B
Operating Income3.89B
Pretax Income182.69M
Net Income49.95M
EBITDA1.69B
Earnings Per Share (EPS)0.22
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
Nectar Lifesciences Ltd. pays an annual dividend of ₹4.319, resulting in a dividend yield of ―
Dividend Per Share₹4.319
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.53
52-Week Price Change-39.35%
50-Day Moving Average22.76
200-Day Moving Average30.47
Relative Strength Index (RSI)38.04
Average Volume (3m)510.26K
Important Dates
Nectar Lifesciences Ltd. upcoming earnings date is Aug 11, 2025, TBA (Confirmed).
Last Earnings DateJul 7, 2025
Next Earnings DateAug 11, 2025
Ex-Dividend DateSep 11, 2020
Financial Position
Nectar Lifesciences Ltd. as a current ratio of 1.32, with Debt / Equity ratio of 0.00%
Current Ratio1.32
Quick Ratio0.52
Debt to Market Cap0.82
Net Debt to EBITDA3.65
Interest Coverage Ratio4.46
Taxes
In the past 12 months, Nectar Lifesciences Ltd. has paid 132.74M in taxes.
Income Tax132.74M
Effective Tax Rate0.73
Enterprise Valuation
Nectar Lifesciences Ltd. EV to EBITDA ratio is 8.26, with an EV/FCF ratio of 7.14.
EV to Sales0.83
EV to EBITDA8.26
EV to Free Cash Flow7.14
EV to Operating Cash Flow6.20
Balance Sheet
Nectar Lifesciences Ltd. has ₹187.35M in cash and marketable securities with ₹0.00 in debt, giving a net cash position of -₹187.35M billion.
Cash & Marketable Securities₹187.35M
Total Debt₹0.00
Net Cash-₹187.35M
Net Cash Per Share-₹0.84
Tangible Book Value Per Share₹44.79
Margins
Gross margin is 25.55%, with operating margin of 23.10%, and net profit margin of 0.30%.
Gross Margin25.55%
Operating Margin23.10%
Pretax Margin1.08%
Net Profit Margin0.30%
EBITDA Margin10.01%
EBIT Margin6.41%
Analyst Forecast
The average price target for Nectar Lifesciences Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―